MedChemComm · 2013 · 24 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryStructural BiologyStructure-activity RelationshipsDrug-receptor InteractionsLigand BindingProtein StructureReceptor-ligand InteractionsStructural Basis Of RecognitionStructure-activity Relationship AnalysisChemical Probe SelectivityChemical Structure-activity RelationshipsDimer InterfaceLigand Binding AffinityReader ProteinsReceptor-ligand Structural BiologyStructure-based Selectivity DesignStructure-guided Lead Discovery
We recently reported the discovery of UNC1215, a potent and selective chemical probe for the L3MBTL3 methyllysine reader domain. In this article, we describe the development of structure-activity relationships (SAR) of a second series of potent L3MBTL3 antagonists which evolved from the structure of the chemical probe UNC1215. These compounds are selective for L3MBTL3 against a panel of methyllysine reader proteins, particularly the related MBT family proteins, L3MBTL1 and MBTD1. A co-crystal structure of L3MBTL3 and one of the most potent compounds suggests that the L3MBTL3 dimer rotates about the dimer interface to accommodate ligand binding.
20
VMD: Visual molecular dynamics
William Humphrey, Andrew Dalke, Klaus Schulten · Journal of Molecular Graphics · 1996 · 66.6K citations
The language of covalent histone modifications
Brian D. Strahl, C. David Allis · Nature · 2000 · 8.6K citations
Active genes are tri-methylated at K4 of histone H3
Helena Santos-Rosa, Robert Schneider, Andrew J. Bannister et al. · Nature · 2002 · 2.2K citations
Jonathan A. Bernstein, Arkady Khodursky, Pei‐Hsun Lin et al. · Proceedings of the National Academy of Sciences · 2002 · 874 citations · Full text
Life Sciences, Biology, Microbiology +16